Browse

You are looking at 701 - 750 of 894 items for :

  • Educational & Training x
  • Refine by Access: All content x
Clear All
Restricted access

2.12: Valproic Acid

Edited by John E. Murphy

Restricted access

2.13: Vancomycin

Edited by John E. Murphy

Restricted access

2.14: Warfarin

Edited by John E. Murphy

Restricted access

2.2: Medication Dosing in Overweight and Obese Patients

Edited by John E. Murphy

Restricted access

2.2 Nutrition—Level 2

Sandra Benavides

Restricted access

2.2 Nutrition—Level 2

Sandra Benavides

Restricted access

2.3: Estimating Creatinine Clearance

Edited by John E. Murphy

Restricted access

2.3 Toxicology—Level 3

Mary A. Babico and Hanna Phan

Restricted access

2.3 Toxicology—Level 3

Mary A. Babico and Hanna Phan

Restricted access

2.4: Renal Drug Dosing

Edited by John E. Murphy

Restricted access

2.5: Aminoglycoside Antibiotics

Edited by John E. Murphy

Restricted access

2.6: Carbamazepine

Edited by John E. Murphy

Restricted access

2.7: Digoxin

Edited by John E. Murphy

Restricted access

2.8: Unfractionated Heparin and Low Molecular Weight Heparins

Edited by John E. Murphy

Restricted access

2.9: Lithium

Edited by John E. Murphy

Restricted access

3.1 Patent Ductus Arteriosus—Level 1

Brady S. Moffett

Restricted access

3.1 Patent Ductus Arteriosus—Level 1

Brady S. Moffett

Restricted access

3.2 Hypertension—Level 2

Brady S. Moffett

Restricted access

3.2 Hypertension—Level 2

Brady S. Moffett

Restricted access

3.3 Congenital Heart Defects—Level 3

Brady S. Moffett

Restricted access

3.3 Congenital Heart Defects—Level 3

Brady S. Moffett

Restricted access

4.1 Asthma—Level 1

Manar O. Lashkar and Hanna Phan

Restricted access

4.1 Asthma—Level 1

Manar O. Lashkar and Hanna Phan

Restricted access

4.2 Cystic Fibrosis—Level 2

Hanna Phan

Restricted access

4.2 Cystic Fibrosis—Level 2

Hanna Phan

Restricted access

4.3 Respiratory Distress Syndrome and Bronchopulmonary Dysplasia—Level 3

Hanna Phan

Restricted access

4.3 Respiratory Distress Syndrome and Bronchopulmonary Dysplasia—Level 3

Hanna Phan

Restricted access

5.1 Constipation—Level 1

Jeremy S. Stultz and Milap C. Nahata

Restricted access

5.1 Constipation—Level 1

Jeremy S. Stultz and Milap C. Nahata

Restricted access

5.2 Crohn Disease—Level 2

Jeremy S. Stultz and Milap C. Nahata

Restricted access

5.2 Crohn Disease—Level 2

Jeremy S. Stultz and Milap C. Nahata

Restricted access

6.1 Nephrotic Syndrome—Level 2

Sandra Benavides

Restricted access

6.1 Nephrotic Syndrome—Level 2

Sandra Benavides

Restricted access

6.2 Acute Kidney Injury—Level 3

Jeremy S. Stultz and Milap C. Nahata

Restricted access

6.2 Acute Kidney Injury—Level 3

Jeremy S. Stultz and Milap C. Nahata

Restricted access

7.1 Type 2 Diabetes Mellitus—Level 1

Sandra Benavides

Restricted access

7.1 Type 2 Diabetes Mellitus—Level 1

Sandra Benavides

Restricted access

7.2 Hypothyroidism—Level 2

Shirin Madzhidova and Sandra Benavides

Restricted access

7.2 Hypothyroidism—Level 2

Shirin Madzhidova and Sandra Benavides

Restricted access

7.3 Diabetic Ketoacidosis—Level 3

Julianna Crain and Sandra Benavides

Restricted access

7.3 Diabetic Ketoacidosis—Level 3

Julianna Crain and Sandra Benavides

Restricted access

8.1 Attention Deficit Hyperactivity Disorder—Level 1

Jennifer E. Thomas and Joshua Caballero

Restricted access

8.1 Attention Deficit Hyperactivity Disorder—Level 1

Jennifer E. Thomas and Joshua Caballero

Restricted access

8.2 Autism Spectrum Disorder—Level 2

Jose Valdes and Jose A. Rey

Restricted access

8.2 Autism Spectrum Disorder—Level 2

Jose Valdes and Jose A. Rey

Restricted access

8.3 Depression—Level 2

Kristen Lamberjack and Christine Prusa

Restricted access

8.3 Depression—Level 2

Kristen Lamberjack and Christine Prusa

Restricted access

8.4 Cerebral Palsy—Level 3

Mary Worthington

Restricted access

8.4 Cerebral Palsy—Level 3

Mary Worthington

Restricted access

8.5 Seizure Disorders—Level 3

Jose Valdes and Jose A. Rey